EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TDP-43 regulates LC3ylation in neural tissue through ATG4B cryptic splicing inhibition

Pascual Torres, Santiago Rico-Rios, Miriam Ceron-Codorniu, Marta Santacreu-Vilaseca, David Seoane-Miraz, Yahya Jad, Victòria Ayala, Guillermo Mariño, Maria Beltran, Maria P Miralles, Pol Andrés-Benito, Joaquin Fernandez-Irigoyen und 9 weitere

Acta Neuropathologica · 2024

DOI: 10.1007/s00401-024-02780-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neuropathologica, 2024. Verfasst von Pascual Torres und 20 weiteren Autor:innen. Beteiligte Einrichtung: Metabolic Pathophysiology Research Group, Department of Experimental Medicine, University of Lleida (UdL), Lleida Biomedical Research Institute (IRBL…. Hauptthemen laut MEDLINE: Autophagy-Related Proteins, DNA-Binding Proteins, Microtubule-Associated Proteins, Amyotrophic Lateral Sclerosis. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Ministerio de Universidades, Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amyotrophic lateral sclerosis (ALS) is an adult-onset motor neuron disease with a mean survival time of three years. The 97% of the cases have TDP-43 nuclear depletion and cytoplasmic aggregation in motor neurons. TDP-43 prevents non-conserved cryptic exon splicing in certain genes, maintaining transcript stability, including ATG4B , which is crucial for autophagosome maturation and Microtubule-associated proteins 1A/1B light chain 3B (LC3B) homeostasis. In ALS mice (G93A), Atg4b depletion worsens survival rates and autophagy function. For the first time, we observed an elevation of LC3ylation in the CNS of both ALS patients and atg4b −/− mouse spinal cords. Furthermore, LC3ylation modulates the distribution of ATG3 across membrane compartments. Antisense oligonucleotides (ASOs) targeting cryptic exon restore ATG4B mRNA in TARDBP knockdown cells. We further developed multi-target ASOs targeting TDP-43 binding sequences for a broader effect. Importantly, our ASO based in peptide-PMO conjugates show brain distribution post-IV administration, offering a non-invasive ASO-based treatment avenue for neurodegenerative diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autophagy-Related ProteinsDNA-Binding ProteinsMicrotubule-Associated ProteinsAmyotrophic Lateral SclerosisCysteine EndopeptidasesAnimalsHumansMiceMaleSpinal CordAutophagyMice, KnockoutRNA SplicingFemaleMice, TransgenicMotor NeuronsOligonucleotides, Antisense

Stichwörter der Autor:innen

ALSAntisense oligonucleotidesAutophagyDigital PCRPost-translational modification

Substanzen

Autophagy-Related ProteinsDNA-Binding ProteinsATG4B protein, humanMicrotubule-Associated ProteinsCysteine EndopeptidasesTARDBP protein, humanAtg4b protein, mouseTardbp protein, mouseOligonucleotides, Antisense

Autor:innen und Institutionen

  • Metabolic Pathophysiology Research Group, Department of Experimental Medicine, University of Lleida (UdL), Lleida Biomedical Research Institute (IRBLleida), 25198, Lleida, Spain.
  • Department of Paediatrics, Institute of Developmental and Regenerative Medicine (IDRM), University of Oxford, Roosevelt Dr, Oxford, OX3 7TY, UK.
  • MDUK Oxford Neuromuscular Centre, University of Oxford, Oxford, UK.
  • Departamento de Biología Funcional, Facultad de Medicina, Universidad de Oviedo, 33006, Oviedo, Spain.
  • Instituto Universitario de Oncología (IUOPA), 33006, Oviedo, Spain.
  • Instituto de Investigación Sanitaria Del Principado de Asturias (ISPA), 33011, Oviedo, Spain.

ORCID-Profile: Manuel Portero-Otin

Förderung

  • Instituto de Salud Carlos III
  • Ministerio de Universidades
  • Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya
  • Fundación Luzon
  • Universitat de Lleida

Zitieren

APA

Torres, P., Rico-Rios, S., Ceron-Codorniu, M., Santacreu-Vilaseca, M., Seoane-Miraz, D., Jad, Y., Ayala, V., Mariño, G., Beltran, M., Miralles, M. P., Andrés-Benito, P., Fernandez-Irigoyen, J., Santamaria, E., López-Otín, C., Soler, R. M., Povedano, M., Ferrer, I., Pamplona, R., Wood, M. J. A., …, & Portero-Otin, M. (2024). TDP-43 regulates LC3ylation in neural tissue through ATG4B cryptic splicing inhibition. Acta Neuropathologica. https://doi.org/10.1007/s00401-024-02780-4

Vancouver

Torres P, Rico-Rios S, Ceron-Codorniu M, Santacreu-Vilaseca M, Seoane-Miraz D, Jad Y, et al. TDP-43 regulates LC3ylation in neural tissue through ATG4B cryptic splicing inhibition. Acta Neuropathologica. 2024. doi:10.1007/s00401-024-02780-4

BibTeX
@article{Torres2024,
  author = {Torres, Pascual and Rico-Rios, Santiago and Ceron-Codorniu, Miriam and Santacreu-Vilaseca, Marta and Seoane-Miraz, David and Jad, Yahya and Ayala, Victòria and Mariño, Guillermo and Beltran, Maria and Miralles, Maria P and Andrés-Benito, Pol and Fernandez-Irigoyen, Joaquin and Santamaria, Enrique and López-Otín, Carlos and Soler, Rosa M and Povedano, Monica and Ferrer, Isidro and Pamplona, Reinald and Wood, Matthew J A and Varela, Miguel A and Portero-Otin, Manuel},
  title = {TDP-43 regulates LC3ylation in neural tissue through ATG4B cryptic splicing inhibition},
  journal = {Acta Neuropathologica},
  year = {2024},
  doi = {10.1007/s00401-024-02780-4}
}
Kostenlos starten →